Drugs / DW1601
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04260555 | Dec 2018 → Dec 2019 | bronchitis | Daewon Pharmaceutical Co., Ltd. | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | DW1601 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04260555 ↗ |
| Route | Oral | “tid PO” NCT04260555 ↗ |